As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Companies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Tamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...

Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

India and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...

The ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...

The economy of attrition is the big new reality of the battlefield. Expensive defences are badly struggling against waves of cheap drones a...

Indian stock markets present attractive opportunities now. Investors with an 18-month outlook should consider deploying funds, especially i...

It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...

SII said, in a statement on Friday that the partnership with IntegriMedical aligns with its vision of 'Health for All' and IntegriMedical's...

Serum Institute of India acquires 20% stake in IntegriMedical for N-FIS drug delivery solution. Adar Poonawalla envisions a needle-free vac...

{image_1} Concept Medical Inc CMI has been granted ‘Breakthrough Device Designation’ from the US Food and Drug Administration FDA for Magic...

Venus Remedies is developing a new drug delivery platform that promises to reduce side effects and cost of cancer medicine by as much as on...

US-Based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.